Filed before 2025Filed 2 December 2021
Cambrian BioPharma Inc raised $92.2M
Cambrian BioPharma Inc, a pharmaceuticals company based in New York, NY, raised $92.2M in a new equity round, according to a filing dated 2 December 2021.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 2 December 2021
- Round
- Equity round
- Amount sold
- $92.2M
- Offering size
- $101M
- Investors so far
- 56
- Based in
- New York, NY
- Website
- cambrianbio.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 89% of the 2,220 tracked raises with an amount filed in 2021, and than 98% of the 40 in pharmaceuticals.
Cambrian BioPharma Inc in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 15 Jul 2026 | New filing | $124M | Not tracked |
| 13 Jan 2025 | Amended filing | $23M | Another raise |
| 22 Dec 2023 | New filing | $7.69M | Another raise |
| 2 Dec 2021 | New filing | $92.2M | This raise |
| 6 May 2021 | New filing | $28.4M | Another raise |
More with Future Ventures on the board
- Gameto, Inc.$44M
- Realta Fusion Inc.$35.5M
- Earthshot Labs PBC$1.7M
- Ockam Inc.$12.5M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.